Jorge Hallak, Elia G Caldini, Thiago A Teixeira, Maria Cassia Mendes Correa, Amaro N Duarte-Neto, Fabiola Zambrano, Anja Taubert, Carlos Hermosilla, Joël R Drevet, Marisa Dolhnikoff, Raul Sanchez, Paulo H N Saldiva
{"title":"透射电子显微镜显示,人类精子中存在 SARS-CoV-2 病毒,并伴有类似 ETosis 的反应。","authors":"Jorge Hallak, Elia G Caldini, Thiago A Teixeira, Maria Cassia Mendes Correa, Amaro N Duarte-Neto, Fabiola Zambrano, Anja Taubert, Carlos Hermosilla, Joël R Drevet, Marisa Dolhnikoff, Raul Sanchez, Paulo H N Saldiva","doi":"10.1111/andr.13612","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Severe acute syndrome coronavirus 2 can invade a variety of tissues, including the testis. Even though this virus is scarcely found in human semen polymerase chain reaction tests, autopsy studies confirm the viral presence in all testicular cell types, including spermatozoa and spermatids.</p><p><strong>Objective: </strong>To investigate whether the severe acute syndrome coronavirus 2 is present inside the spermatozoa of negative polymerase chain reaction-infected men up to 3 months after hospital discharge.</p><p><strong>Materials and methods: </strong>This cross-sectional study included 13 confirmed moderate-to-severe COVID-19 patients enrolled 30-90 days after the diagnosis. Semen samples were obtained and examined with real-time polymerase chain reaction for RNA detection and by transmission electron microscopy.</p><p><strong>Results: </strong>In moderate-to-severe clinical scenarios, we identified the severe acute syndrome coronavirus 2 inside spermatozoa in nine of 13 patients up to 90 days after discharge from the hospital. Moreover, some DNA-based extracellular traps were reported in all studied specimens.</p><p><strong>Discussion and conclusion: </strong>Although severe acute syndrome coronavirus 2 was not present in the infected men's semen, it was intracellularly present in the spermatozoa till 3 months after hospital discharge. The Electron microscopy (EM) findings also suggest that spermatozoa produce nuclear DNA-based extracellular traps, probably in a cell-free DNA-dependent manner, similar to those previously described in the systemic inflammatory response to COVID-19. In moderate-to-severe cases, the blood-testes barrier grants little defence against different pathogenic viruses, including the severe acute syndrome coronavirus 2. The virus could also use the epididymis as a post-testicular route to bind and fuse to the mature spermatozoon and possibly accomplish the reverse transcription of the single-stranded viral RNA into proviral DNA. These mechanisms can elicit extracellular cell-free DNA formation. The potential implications of our findings for assisted conception must be addressed, and the evolutionary history of DNA-based extracellular traps as preserved ammunition in animals' innate defence might improve our understanding of the severe acute syndrome coronavirus 2 pathophysiology in the testis and spermatozoa.</p>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Transmission electron microscopy reveals the presence of SARS-CoV-2 in human spermatozoa associated with an ETosis-like response.\",\"authors\":\"Jorge Hallak, Elia G Caldini, Thiago A Teixeira, Maria Cassia Mendes Correa, Amaro N Duarte-Neto, Fabiola Zambrano, Anja Taubert, Carlos Hermosilla, Joël R Drevet, Marisa Dolhnikoff, Raul Sanchez, Paulo H N Saldiva\",\"doi\":\"10.1111/andr.13612\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Severe acute syndrome coronavirus 2 can invade a variety of tissues, including the testis. Even though this virus is scarcely found in human semen polymerase chain reaction tests, autopsy studies confirm the viral presence in all testicular cell types, including spermatozoa and spermatids.</p><p><strong>Objective: </strong>To investigate whether the severe acute syndrome coronavirus 2 is present inside the spermatozoa of negative polymerase chain reaction-infected men up to 3 months after hospital discharge.</p><p><strong>Materials and methods: </strong>This cross-sectional study included 13 confirmed moderate-to-severe COVID-19 patients enrolled 30-90 days after the diagnosis. Semen samples were obtained and examined with real-time polymerase chain reaction for RNA detection and by transmission electron microscopy.</p><p><strong>Results: </strong>In moderate-to-severe clinical scenarios, we identified the severe acute syndrome coronavirus 2 inside spermatozoa in nine of 13 patients up to 90 days after discharge from the hospital. Moreover, some DNA-based extracellular traps were reported in all studied specimens.</p><p><strong>Discussion and conclusion: </strong>Although severe acute syndrome coronavirus 2 was not present in the infected men's semen, it was intracellularly present in the spermatozoa till 3 months after hospital discharge. The Electron microscopy (EM) findings also suggest that spermatozoa produce nuclear DNA-based extracellular traps, probably in a cell-free DNA-dependent manner, similar to those previously described in the systemic inflammatory response to COVID-19. In moderate-to-severe cases, the blood-testes barrier grants little defence against different pathogenic viruses, including the severe acute syndrome coronavirus 2. The virus could also use the epididymis as a post-testicular route to bind and fuse to the mature spermatozoon and possibly accomplish the reverse transcription of the single-stranded viral RNA into proviral DNA. These mechanisms can elicit extracellular cell-free DNA formation. The potential implications of our findings for assisted conception must be addressed, and the evolutionary history of DNA-based extracellular traps as preserved ammunition in animals' innate defence might improve our understanding of the severe acute syndrome coronavirus 2 pathophysiology in the testis and spermatozoa.</p>\",\"PeriodicalId\":3,\"journal\":{\"name\":\"ACS Applied Electronic Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Electronic Materials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/andr.13612\",\"RegionNum\":3,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ENGINEERING, ELECTRICAL & ELECTRONIC\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/andr.13612","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/12 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0
摘要
背景:严重急性综合征冠状病毒 2 可侵入多种组织,包括睾丸。尽管在人类精液聚合酶链反应检测中很少发现这种病毒,但尸检研究证实,病毒存在于所有类型的睾丸细胞中,包括精子和精子细胞:调查出院后 3 个月内聚合酶链反应阴性的男性精子中是否存在严重急性综合征冠状病毒 2:这项横断面研究包括 13 名确诊为中重度 COVID-19 的患者,他们在确诊后 30-90 天入院。研究人员采集了精液样本,并通过实时聚合酶链反应检测 RNA 和透射电子显微镜进行检查:结果:在中度至重度临床病例中,我们在13名患者中的9名患者出院后90天内的精子中发现了严重急性综合征冠状病毒2。此外,在所有研究标本中都发现了一些基于 DNA 的细胞外陷阱:讨论与结论:虽然受感染男性的精液中不存在严重急性综合征冠状病毒2,但直到出院后3个月,精子中仍存在该病毒。电子显微镜(EM)研究结果还表明,精子会产生以核DNA为基础的细胞外捕获器,可能是以一种无细胞DNA依赖的方式产生的,这与之前描述的COVID-19全身炎症反应中的捕获器类似。在中度至重度病例中,血液-睾丸屏障对包括严重急性综合征冠状病毒 2 在内的各种致病病毒的防御能力很弱。病毒还可能利用附睾作为睾丸后途径,与成熟精子结合和融合,并可能完成将单链病毒 RNA 逆转录为前病毒 DNA 的过程。这些机制可导致细胞外无细胞 DNA 的形成。我们的研究结果对辅助受孕的潜在影响必须得到解决,而基于DNA的细胞外陷阱作为动物先天防御的保留弹药的进化史,可能会提高我们对严重急性综合征冠状病毒2在睾丸和精子中的病理生理学的理解。
Transmission electron microscopy reveals the presence of SARS-CoV-2 in human spermatozoa associated with an ETosis-like response.
Background: Severe acute syndrome coronavirus 2 can invade a variety of tissues, including the testis. Even though this virus is scarcely found in human semen polymerase chain reaction tests, autopsy studies confirm the viral presence in all testicular cell types, including spermatozoa and spermatids.
Objective: To investigate whether the severe acute syndrome coronavirus 2 is present inside the spermatozoa of negative polymerase chain reaction-infected men up to 3 months after hospital discharge.
Materials and methods: This cross-sectional study included 13 confirmed moderate-to-severe COVID-19 patients enrolled 30-90 days after the diagnosis. Semen samples were obtained and examined with real-time polymerase chain reaction for RNA detection and by transmission electron microscopy.
Results: In moderate-to-severe clinical scenarios, we identified the severe acute syndrome coronavirus 2 inside spermatozoa in nine of 13 patients up to 90 days after discharge from the hospital. Moreover, some DNA-based extracellular traps were reported in all studied specimens.
Discussion and conclusion: Although severe acute syndrome coronavirus 2 was not present in the infected men's semen, it was intracellularly present in the spermatozoa till 3 months after hospital discharge. The Electron microscopy (EM) findings also suggest that spermatozoa produce nuclear DNA-based extracellular traps, probably in a cell-free DNA-dependent manner, similar to those previously described in the systemic inflammatory response to COVID-19. In moderate-to-severe cases, the blood-testes barrier grants little defence against different pathogenic viruses, including the severe acute syndrome coronavirus 2. The virus could also use the epididymis as a post-testicular route to bind and fuse to the mature spermatozoon and possibly accomplish the reverse transcription of the single-stranded viral RNA into proviral DNA. These mechanisms can elicit extracellular cell-free DNA formation. The potential implications of our findings for assisted conception must be addressed, and the evolutionary history of DNA-based extracellular traps as preserved ammunition in animals' innate defence might improve our understanding of the severe acute syndrome coronavirus 2 pathophysiology in the testis and spermatozoa.